fashion -WSS

fashion

author：entertainment 2025-09-28 21:57:24 - browse：33

Daphne Koller -- biotech coverage from STAT — Daphne Koller, early biotech AI entrant Insitro's founder, CEO and board member. Courtesy Jerrick Mitra/Insitro

New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet.

Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. It raised more than $643 million in venture capital, according to PitchBook, from investors including T. Rowe Price, ARCH Venture Partners, and Casdin Capital. The company now has more than 260 employees spread out over 107,000 square feet of laboratory and office space.

But what exactly is Koller building?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： Is it ever OK for doctors to lie to their patients?

WSS

Study points to new risk in gene therapy death of Terry Horgan

Class action alleges UnitedHealth concealed DOJ probe

Primary care doctor shortage won't be solved by free med school tuition

Primary care doctor shortage won't be solved by free med school tuition

Some top drug companies are starting to take action on climate

What will Novo Nordisk's VC do with its influx of cash?

knowledge

fashion

explore

Sports medicine is finally prioritizing gender equality

AltruBio raises $225 million to develop ulcerative colitis drug

How one medical school became remarkably diverse

European officials brace for rough respiratory virus season

23andMe had bad news about my health. I wish a person had delivered it

AI for drug discovery: Experts on separating hype from reality

Cancer drug shortages should be causing more outrage

WHO recommends second malaria vaccine

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Warren pushes Witty on UnitedHealth's control over physicians

focus

Sepsis can kill a child within hours. Here's how hospitals are fighting back

CDC picks Alphabet's Verily for wasterwater surveillance contract

Black vets could get higher VA benefits if race not used in lung test

Deliver public health messages at the right time

Study points to new risk in gene therapy death of Terry Horgan

The United States is paying nearly triple for new Covid vaccines

leisure time

focus

focus

knowledge